Skip to main content
Premium Trial:

Request an Annual Quote

Ariadne, Quertle Partner to Improve Search Results

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ariadne and Quertle today announced a partnership to use Ariadne's technology to enhance search results from Quertle's search engine for biomedical literature.

Ariadne will also provide technical resources to the partnership. Financial terms were not disclosed.

Quertle is a search engine that uses semantic-driven text analytics "to find conceptual relationships scattered throughout a document," the companies said in a joint statement. In addition to using query terms, Quertle's Power Terms technology identifies key concepts and provides the "most relevant literature" in search results.

Under the collaboration, components of Ariadne's MedScan technology, comprised of a set of patent-pending algorithms, will be used to enhance the search engine to enable "highly quality information and data retrieval" from publicly available information, text, journals, and datasets, the two companies said. The extracted data is then translated into biological relationships "which supports a wide range of biological applications," such as Ariadne's Pathway Studio software.

Ariadne will also package Quertle's semantic search engine as an appliance solution to the pharmaceutical and agricultural industry.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.